4//SEC Filing
Hamill John P. 4
Accession 0001104659-25-029920
CIK 0001781983other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:31 PM ET
Size
7.5 KB
Accession
0001104659-25-029920
Insider Transaction Report
Form 4
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Transactions
- Award
Stock Options (Right to Buy)
2025-03-27+13,460→ 13,460 totalExercise: $2.20Exp: 2035-03-28→ Common Stock (13,460 underlying) - Award
Common Stock
2025-03-27+3,365→ 22,733 total
Footnotes (2)
- [F1]These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 27, 2026, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Twenty-five percent of these options vest on March 27, 2026, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001716213
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:31 PM ET
- Size
- 7.5 KB